Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
IMI-Mab logo

I-Mab (IMAB)

NASDAQ Global Market · Currency in USD
$2.88 ▼ -0.02 (-0.69%)
At close: Mar 17, 9:30 AM ET. Market closed.

Summary

Previous Close
$2.90
Open
$2.90
Day's Range
$2.81 – $3.01
52 Week Range
$0.60 – $6.79
Volume
892,600
Avg. Volume
1,882,343
Market Cap
$542.01M
Beta (5Y Monthly)
1.46
PE Ratio (TTM)
--
EPS (TTM)
-$0.27
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$7.75

Profile: I-Mab

Sector
Healthcare
Industry
Biotechnology
Full-time employees
32
CEO
Xi-Yong Fu

I-Mab is a biopharmaceutical company, operating at the clinical stage, dedicated to the discovery, advancement, and commercialization of biologic therapies. Its core mission is to address critical medical needs in both oncology and autoimmune diseases. The company boasts a comprehensive pipeline of drug candidates.

Earnings

DateEst.Actual
Nov 13, 2025-$0.06-$0.25Miss
Aug 20, 2025-$0.10-$0.07Beat
May 15, 2025-$0.06-$0.00Beat
Mar 31, 2025-$0.06-$0.01Beat
Nov 14, 2024-$0.16-$0.25Miss
Aug 28, 2024-$0.51-$0.07Beat

Analyst view

Consensus price target
$7.75 ▲ +169.1%
Range $7.00 – $9.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on IMAB and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.